CIITA is not a cytotoxic target; it is knocked out in the donor T cells to reduce MHC II expression and allorecognition. Killing is directed at CD19+ cells via STAR receptor engagement, triggering TCR–CD3 signaling and cytolysis (perforin/granzymes/Fas pathways).